February has seen published results which show that 2022 has been good for Cigna and Allianz, with IPMI one of the drivers. Both companies are featured multiple times evidencing their commitment to growth and innovation through rebranding and reorganisation / new products, respectively. The MMB report on IPMI is also a worthy read, especially conclusion 4 on changing work patterns.

Elsewhere, end of 2022 year reports confirm the catastrophic financial story for many large US provider groups, perhaps indicating that these losses will be clawed  back from all buyers in 2023/4.

Teladoc’s massive goodwill write off following the ‘crazy’ price it paid for Livongo is only shocking due to its scale.

We also feature some articles on the advances and challenges around the use of AI in healthcare provision, and services, as this trend starts to surface.

We hope these selections continue to inspire you.